These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 5897862)

  • 1. [Clinical and bacteriological problems of ethionamide therapy].
    Lányi M
    Z Tuberk Erkr Thoraxorg; 1965 Jul; 123(4):332-4. PubMed ID: 5897862
    [No Abstract]   [Full Text] [Related]  

  • 2. [One-year results of initial therapy of cavernous pulmonary tuberculosis with isoniazid, streptomycin and ethionamide].
    Zajaczkowska J; Krychniak W; Krakówka P; Buraczewska M
    Gruzlica; 1965 Jul; 33(7):565-70. PubMed ID: 5849562
    [No Abstract]   [Full Text] [Related]  

  • 3. Experiences with ethionamide in chronic drug-failure cases of pulmonary tuberculosis.
    Mitra A
    Minerva Medicoleg; 1965; 85(3):29-33. PubMed ID: 5879932
    [No Abstract]   [Full Text] [Related]  

  • 4. Cycloserine in the treatment of pulmonary tuberculosis.
    Aceves Ortega R; Cortés de la Peña F; Sanchez Ceceña S; Arreola Chavez C
    Scand J Respir Dis Suppl; 1970; 71():109-14. PubMed ID: 5271969
    [No Abstract]   [Full Text] [Related]  

  • 5. Results of one-year chemotherapy with isoniazid (INH), streptomycin (SM) and ethionamide (ETA) in previously untreated patients with cavernous pulmonary tuberculosis.
    Zajaczkowska J; Krychniak W; Krakówka P; Buraczewska M
    Pol Med J; 1966; 5(2):339-44. PubMed ID: 5915720
    [No Abstract]   [Full Text] [Related]  

  • 6. Tuberculous meningitis due to primary drug-resistant Mycobacterium tuberculosis hominis.
    Bonforte RJ; Karpas CM; Gribetz I; Shanzer S
    Pediatrics; 1968 Dec; 42(6):969-75. PubMed ID: 4973145
    [No Abstract]   [Full Text] [Related]  

  • 7. [Treatment of 100 pulmonary tubercular patients whose bacilli are resistant to streptomycin, isoniazid and ethionamid, with a combination of rifampicin and ethambutol. Comparison between 2 dosages of rifampicin (weekly treatment for 4 months, biweekly for 8 months after)].
    Hétrick G; Muñoz I; Ras R
    Rev Tuberc Pneumol (Paris); 1970; 34(5):715-6. PubMed ID: 5496795
    [No Abstract]   [Full Text] [Related]  

  • 8. [Thiocarlide. Attempt of an evaluation].
    Protivinsky R
    Ther Ggw; 1969 Oct; 108(10):1410-1 passim. PubMed ID: 4908478
    [No Abstract]   [Full Text] [Related]  

  • 9. [Some questions on chemotherapy with ethionamide].
    Utkin VV; Fedorova IE
    Probl Tuberk; 1967; 45(7):49-55. PubMed ID: 4974096
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparison of ethionamide with isoniazid in original treatment cases of pulmonary tuberculosis. XIV. A report of the Veterans Administration--Armed Forces cooperative study.
    Schwartz WS
    Am Rev Respir Dis; 1966 May; 93(5):685-92. PubMed ID: 5936929
    [No Abstract]   [Full Text] [Related]  

  • 11. [On qualitative demonstration of tuberculostatics in the control of taking of drugs].
    Grunert M; Reutgen H; Iwainsky H
    Z Tuberk Erkr Thoraxorg; 1965; 124(3):141-8. PubMed ID: 5899136
    [No Abstract]   [Full Text] [Related]  

  • 12. [The four-fold treatment of serious forms of pulmonary tuberculosis].
    Amsler R
    Sem Ther; 1966; 42(6):365-6. PubMed ID: 5984624
    [No Abstract]   [Full Text] [Related]  

  • 13. [Intravenous hormono-chemotherapy of pulmonary tuberculosis in case of drug-resistant mycobacteria].
    Repin IuM; Saburenkova EP
    Vrach Delo; 1969 Feb; 2():61-3. PubMed ID: 4305290
    [No Abstract]   [Full Text] [Related]  

  • 14. Limitations of the clinical activity of cycloserine therapy. Appearance of resistance to cycloserine when used alone and in combination with other drugs.
    Molina C
    Scand J Respir Dis Suppl; 1970; 71():296-305. PubMed ID: 5272000
    [No Abstract]   [Full Text] [Related]  

  • 15. [Attempt at intermittent chemotherapeutic treatment of patients with bacilli resistant to streptomycin and isoniazid (cooperative survey by the antitubercular services of Marrakech, Meknes, Tangiers)].
    Burzoni FJ; Chicou FJ; Durante C; Hetrick G; Ras R
    Rev Tuberc Pneumol (Paris); 1969 Nov; 33(7):975-86. PubMed ID: 5403000
    [No Abstract]   [Full Text] [Related]  

  • 16. [Association of ethionamide, isoniazid and ethambutol in the therapy of pulmonary tuberculosis].
    Zanotelli F
    Fracastoro; 1967; 60(6):594-607. PubMed ID: 5617704
    [No Abstract]   [Full Text] [Related]  

  • 17. [Comparison of 2 intermittent therapeutic regimens: ethionamide-isoniazid and streptomycin-isoniazid].
    Lahlou M
    Bull Int Union Tuberc; 1970 Jun; 43():289-94. PubMed ID: 5425557
    [No Abstract]   [Full Text] [Related]  

  • 18. [Improved therapy of tuberculosis with a well tolerated INH derivative (INHG)].
    Sighart H; Opl G
    Wien Klin Wochenschr; 1969 Nov; 81(46):840-1. PubMed ID: 5380791
    [No Abstract]   [Full Text] [Related]  

  • 19. Position of cycloserine in the treatment of pulmonary tuberculosis.
    Meyer A; Nadjar G
    Scand J Respir Dis Suppl; 1970; 71():139-43. PubMed ID: 5271974
    [No Abstract]   [Full Text] [Related]  

  • 20. [Ethionamide and tubazid in the therapy of pulmonary tuberculosis].
    Pudoĭ NM; Iampol'skaia SA
    Klin Med (Mosk); 1969 Dec; 47(12):74-9. PubMed ID: 5382417
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.